16:00 - 17:00
ET
Webcast
Deep dive into DLBCL: Diagnosis to treatment of diffuse large B-cell lymphoma
Join healthcare expert and researcher, Dr. John Kuruvilla, for this 1-hour live online presentation where he will discuss diagnosis and approach to managing DLBCL, the most commonly diagnosed subtype of non-Hodgkin lymphoma.
This free webcast is for people recently diagnosed with DLBCL, individuals in treatment, those living with DLBCL, and their caregivers and families - to learn about the medical and scientific work to improve outcomes and save more lives through research and treatment advances for DLBCL.
Dr. John Kuruvilla
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre (PM) in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs. He is also the Co-Director of the High Definition Therapeutics Strategic Pillar for PM.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
This event was made possible thanks to the support of:
